COLL vs GNRC · P/E 17, rev $181.9M vs P/E 82, rev $4.21B
Collegium Pharmaceutical Inc (COLL) versus Generac Holdings Inc (GNRC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported GNRC revenue for 2025-12-31 was $4.21B. Net income was $159.6M. Revenue was down 2.0% from 2024-12-31 to 2025-12-31. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Not investment advice. Open the COLL and GNRC stock pages for the full models.
Not investment advice.